Homepage

Innovative technologies for human well-being

Medical solutions developed to achieve a positive and tangible impact on people’s lives.

Who we are

Innovative technologies for human well-being

Medical solutions developed to achieve a positive and tangible impact on people’s lives.

Who we are

Who we are - The Group

In the spirit of innovation and the strengthening of an ever-evolving and growing industry, NUMANTEC, was born. It’s the new biomedical group composed of various entities specialized in healthcare solutions.

Today, the network is the essential tool for individual growth. The union of similar entities creates the optimal conditions for progress and development, allowing for the expansion of the target market, strengthening communication with suppliers, and establishing the appropriate framework for both individual and group growth.

The combination of different companies, united by ideals and growth thrusts, has enabled the creation of a strong, yet dynamic Group, capable of entering the European and global arena compact and cohesive.
The variety of available products and the individual expertise will enable the group to continue growing and structuring itself, aiming to become the global benchmark in the biomedical field.

Who we are -
the Group

In the spirit of innovation and the strengthening of an ever-evolving and growing industry, NUMANTEC, was born. It’s the new biomedical group composed of various entities specialized in healthcare solutions.

Today, the network is the essential tool for individual growth. The union of similar entities creates the optimal conditions for progress and development, allowing for the expansion of the target market, strengthening communication with suppliers, and establishing the appropriate framework for both individual and group growth.

The combination of different companies, united by ideals and growth thrusts, has enabled the creation of a strong, yet dynamic Group, capable of entering the European and global arena compact and cohesive.
The variety of available products and the individual expertise will enable the group to continue growing and structuring itself, aiming to become the global benchmark in the biomedical field.

MISSION

Innovation and Cohesion at the Core of Our Work

The various entities that make up Numantec specialize in one-of-a-kind, innovative, and cutting-edge healthcare solutions. The constant search for Functional, Safe and Quality solutions enable the Group to set a benchmark in the world market. The continuous pursuit of functional, safe, and quality solutions allows the group to position itself as a global reference point. We listen to healthcare professionals and build the best possible solution to reduce human error and ensure optimal performance, always with a focus on the end patient.

VISION

Helping the patient live his or her daily life

Our goal is always to seek the excellent solution to improve patients' quality of life and enable them to live their daily lives to the fullest even while performing the simplest actions.
Numantec is constantly looking for practical, state-of-the-art solutions that can lead to real benefit for those who use our products.

MISSION

Innovation and Cohesion at the Core of Our Work

The various entities that make up Numantec specialize in one-of-a-kind, innovative, and cutting-edge healthcare solutions. The constant search for Functional, Safe and Quality solutions enable the Group to set a benchmark in the world market. The continuous pursuit of functional, safe, and quality solutions allows the group to position itself as a global reference point. We listen to healthcare professionals and build the best possible solution to reduce human error and ensure optimal performance, always with a focus on the end patient.

VISION

Helping the patient live his or her daily life

Our goal is always to seek an excellent solution to improve the quality of life for patients and enable them to fully experience their daily lives, even when performing the simplest tasks. Numantec is constantly looking for practical, state-of-the-art solutions that can lead to real benefit for those who use our products.

The individual companies

The individual companies

Le singole aziende

The individual companies

History: The Group

History: The Group

1993


Delta Med was born

2017-2018


Acquisition of Tipromed, the business unit of Alfa Med and BEL

2021


WBI acquires 90% of Delta Med's capital

2022


Acquisition of Adria Med and Pentaferte

2023


Acquisition of D.B.M.

1993


Delta Med was born

2017-2018


Acquisition of Tipromed, the business unit of Alfa Med and BEL

2021


WBI acquires 90% of Delta Med's capital

2022


Acquisition of Adria Med and Pentaferte

2023


Acquisition of D.B.M.

1980


Pentaferte was born

1990


Adria Med was born

1993


Delta Med was born

1997


Pentaferte opens Pentaferte France
as the Italian branch

2006


D.B.M. starts its business as a sole proprietorship

2017


Acquisition of Tipromed, the business unit of Alfa Med and BEL

2021


WBI acquires 90% of Delta Med's capital

2022


Acquisition of Adria Med and Pentaferte

2023


Acquisition of D.B.M.

"A group of people who share a common goal can achieve the impossible."

"A group of people who share a common goal can achieve the impossible."

People

People

GABRIELE GIOVANELLI

Group CEO
CEO Delta Med

For years engaged in the biomedical industry, he has been part of major multinational companies holding top positions and quickly achieving their goals, increasing revenues and successfully completing different acquisitions.

FRANCESCO DI FLORIO

Business Development Infusion Systems CEO Adriamed

Engaged in manufacturing and marketing companies for children’s products, he specialized both domestically and internationally and later devoted himself to research and development of innovative medical device solutions such as infusion systems and elastomeric infusion pumps.

GIANLUCA ROMAGNOLI

Business Development Drug Delivery President Pentaferte

Specializing in marketing and business development, he brings his background within the Group to support growth and development that will enable Numantec to appear solidly on the international scene.

GABRIELE GIOVANELLI

Group CEO
CEO Delta Med

For years engaged in the biomedical industry, he has been part of major multinational companies holding top positions and quickly achieving their goals, increasing revenues and successfully completing different acquisitions.

FRANCESCO DI FLORIO

Business Development Infusion Systems CEO Adriamed

Engaged in manufacturing and marketing companies for children’s products, he specialized both domestically and internationally and later devoted himself to research and development of innovative medical device solutions such as infusion systems and elastomeric infusion pumps.

GIANLUCA ROMAGNOLI

Business Development Drug Delivery President Pentaferte

Specializing in marketing and business development, he brings his background within the Group to support growth and development that will enable Numantec to appear solidly on the international scene.

XAVIER MESNIL

CEO Pentaferte France

His knowledge of Pentaferte-branded products but also the skills he has acquired in the management and commercial distribution of international brands enable him to boast enviable know-how in support of strong commercial growth for the entire group.

CRISTINA GEORGESCU

Securmed CEO

Attentive and responsive to change, it has also seized the opportunity of the Group’s birth to support the growth and acceleration of individual components. Strategic and innovative, its vision will ensure continued growth for the entire Group.

ROBERTO CADRINGHER

CEO D.B.M.

Starts its business by providing printing services on medical products and assembling medical devices. He then creates the Research and Development department from which unique and strategic products are created. Constant research and innovation are fundamental pillars of the Group’s growth.

XAVIER MESNIL

CEO Pentaferte France

His knowledge of Pentaferte-branded products but also the skills he has acquired in the management and commercial distribution of international brands enable him to boast enviable know-how in support of strong commercial growth for the entire group.

CRISTINA GEORGESCU

Securmed CEO

Attentive and responsive to change, it has also seized the opportunity of the Group’s birth to support the growth and acceleration of individual components. Strategic and innovative, its vision will ensure continued growth for the entire Group.

ROBERTO CADRINGHER

CEO D.B.M.

Starts its business by providing printing services on medical products and assembling medical devices. He then creates the Research and Development department from which unique and strategic products are created. Constant research and innovation are fundamental pillars of the Group’s growth.